EUVIMEDEUVIMED entdecken
Open Access

SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1

Dylan J Tuttle iD, Priscila M S Castanha iD, Amro Nasser, Maris S Wilkins, Tamara García Galarza, Mounia Alaoui-El-Azher, Deirdre E Cuff, Prabal Chhibbar, Jishnu Das, Yijia Li iD, Simon M Barratt-Boyes, Robbie B Mailliard und 3 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Dylan J Tuttle und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA. Hauptthemen laut MEDLINE: Complement Activation, COVID-19, COVID-19 Vaccines, HIV-1. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Immune dysregulation in people with human immunodeficiency virus-1 (PWH) persists despite potent antiretroviral therapy and, consequently, PWH tend to have lower immune responses to licensed vaccines. However, limited information is available about the impact of mRNA vaccines in PWH. This study details the immunologic responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccines in PWH and their impact on HIV-1.

Methods

We quantified anti-S immunoglobulin G (IgG) binding and neutralization of 3 SARS-CoV-2 variants of concern and complement activation in blood from virally suppressed men with HIV-1 (MWH) and men without HIV-1 (MWOH), and the characteristics that may impact the vaccine immune responses. We also studied antibody levels against HIV-1 proteins and HIV-1 plasma RNA.

Results

MWH had lower anti-S IgG binding and neutralizing antibodies against the 3 variants compared to MWOH. MWH also produced anti-S1 antibodies with a 10-fold greater ability to activate complement and exhibited higher C3a blood levels than MWOH. MWH had decreased residual HIV-1 plasma viremia and anti-Nef IgG approximately 100 days after immunization.

Conclusions

MWH respond to SARS-CoV-2 mRNA vaccines with lower antibody titers and with greater activation of complement, while exhibiting a decrease in HIV-1 viremia and anti-Nef antibodies. These results suggest an important role of complement activation mediating protection in MWH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Complement ActivationCOVID-19COVID-19 VaccinesHIV-1HumansMaleAntibodies, NeutralizingAntibodies, ViralHIV SeropositivityImmunoglobulin GmRNA VaccinesSARS-CoV-2Viremia

Stichwörter der Autor:innen

COVID-19HIV-1SARS-CoV-2 vaccinesantibodiescomplement system

Substanzen

Antibodies, NeutralizingAntibodies, ViralCOVID-19 VaccinesImmunoglobulin GmRNA Vaccines

Autor:innen und Institutionen

  • Department of Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, USA.
  • Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
  • Department of Virology and Experimental Therapeutics, Instituto Aggeu, Magalhães, Fundação Oswaldo Cruz, Recife, Pernambuco, Brazil.

ORCID-Profile: Dylan J Tuttle, Priscila M S Castanha, Yijia Li, Ernesto T A Marques

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • National Institutes of Health
  • National Research Service Award
  • National Institute of Allergy and Infectious Diseases
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Tuttle, D. J., Castanha, P. M. S., Nasser, A., Wilkins, M. S., Galarza, T. G., Alaoui-El-Azher, M., Cuff, D. E., Chhibbar, P., Das, J., Li, Y., Barratt-Boyes, S. M., Mailliard, R. B., Sluis-Cremer, N., Rinaldo, C. R., & Marques, E. T. A. (2024). SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad544

Vancouver

Tuttle DJ, Castanha PMS, Nasser A, Wilkins MS, Galarza TG, Alaoui-El-Azher M, et al. SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad544

BibTeX
@article{Tuttle2024,
  author = {Tuttle, Dylan J and Castanha, Priscila M S and Nasser, Amro and Wilkins, Maris S and Galarza, Tamara García and Alaoui-El-Azher, Mounia and Cuff, Deirdre E and Chhibbar, Prabal and Das, Jishnu and Li, Yijia and Barratt-Boyes, Simon M and Mailliard, Robbie B and Sluis-Cremer, Nicolas and Rinaldo, Charles R and Marques, Ernesto T A},
  title = {SARS-CoV-2 mRNA Vaccines Induce Greater Complement Activation and Decreased Viremia and Nef Antibodies in Men With HIV-1},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad544}
}
Kostenlos starten →